Iron-deficiency anemia

ICD-10 D50 · ICD-11 3A00

Iron-deficiency anemia when oral iron supplementation has not worked

This protocol addresses patients with iron-deficiency anemia whose hemoglobin and ferritin did not respond adequately to a course of oral iron — and who therefore need a different approach.

Previous line did not meet goals

When oral iron supplementation falls short

Oral iron supplementation — typically ferrous sulfate as the preferred first-choice formulation (with ferrous fumarate or ferrous gluconate as alternatives), taken once daily or on alternate days with vitamin C added to aid absorption — is the established first-line intervention.

This protocol becomes relevant when that approach has not achieved its targets:

  • Hemoglobin has not increased by at least 1 g/dL within 2 weeks of adherent therapy, or
  • Ferritin has not improved within one month.
Next-line approach

What comes next

When oral iron has not been effective or is not tolerated, intravenous iron therapy is the indicated route — with specific formulations preferred for their ability to replenish stores efficiently. Full formulation selection and clinical decision criteria are in the complete protocol.

References

DOI: 10.1016/j.cgh.2024.03.046

  • Intravenous iron should be used if the patient does not tolerate oral iron, ferritin levels do not improve with a trial of oral iron, or the patient has a condition in which oral iron is not likely to be absorbed.
  • Intravenous iron formulations that can replace iron deficits with 1 or 2 infusions are preferred over those that require more than 2 infusions.
  • Because there is little difference in overall efficacy of iron repletion and similar risks, formulations that can replace iron deficits with 1 to 2 infusions are preferred.
View source ↗